Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;396(2):229-238.
doi: 10.1007/s00210-022-02302-7. Epub 2022 Oct 17.

Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight

Affiliations
Review

Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight

Champa Keeya Tudu et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Feb.

Abstract

Cryptolepine (1,5-methyl-10H-indolo[3,2-b]quinoline), an indoloquinoline alkaloid, found in the roots of Cryptolepis sanguinolenta (Lindl.) Schltr (family: Periplocaceae), is associated with the suppression of cancer and protozoal infections. Cryptolepine also exhibits anti-bacterial, anti-fungal, anti-hyperglycemic, antidiabetic, anti-inflammatory, anti-hypotensive, antipyretic, and antimuscarinic properties. This review of the latest research data can be exploited to create a basis for the discovery of new cryptolepine-based drugs and their analogues in the near future. PubMed, Scopus, and Google Scholar databases were searched to select and collect data from the existing literature on cryptolepine and their pharmacological properties. Several in vitro studies have demonstrated the potential of cryptolepine A as an anticancer and antimalarial molecule, which is achieved through inhibiting DNA synthesis and topoisomerase II. This review summarizes the recent developments of cryptolepine pharmacological properties and functional mechanisms, providing information for future research on this natural product.

Keywords: Anti-inflammatory; Antimalarial; Antitumor; Cryptolepine; Cryptolepis sanguinolenta; Hepatoprotective; Pharmacology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Chemical structure of 1 cryptolepine and 2 neocryptolepine/cryptotackieine
Fig. 2
Fig. 2
Diagram with the relevant pharmacological properties of cryptolepine and its analogues, derivatives, and their potential mechanism of actions

Similar articles

Cited by

References

    1. Wright CW, Addae-Kyereme J, Breen AG, Brown JE, Cox MF, Croft SL, Gökçek Y, Kendrick H, Phillips RM, Pollet PL. Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. J Med Chem. 2001;44(19):3187–3194. doi: 10.1021/jm010929+. - DOI - PubMed
    1. Zhu H, Gooderham NJ. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells. Toxicol Sci. 2006;91(1):132–139. doi: 10.1093/toxsci/kfj146. - DOI - PubMed
    1. Abacha YZ, Forkuo AD, Gbedema SY, Mittal N, Ottilie S, Rocamora F, Winzeler EA, van Schalkwyk DA, Kelly JM, Taylor MC, Reader J (2022) Semi-synthetic analogues of cryptolepine as a potential source of sustainable drugs for the treatment of malaria, Human African Trypanosomiasis and Cancer - PMC - PubMed
    1. Ameyaw EO, Koffuor GA, Asare KK, Konja D, Du-Bois A, Kyei S, Forkuo AD, Mensah RNAO. Cryptolepine, an indoloquinoline alkaloid, in the management of diabetes mellitus and its associated complications. J Intercult Ethnopharmacol. 2016;5(3):263. doi: 10.5455/jice.20160606124435. - DOI - PMC - PubMed
    1. Ansha C, Mensah KB. A review of the anticancer potential of the antimalarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Ghana Med J. 2013;47(3):137–147. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources